After five years of minimal change in total patents granted, 2019 finally broke the plateau. According to a 2019 USPTO patent statistics analysis using Anaqua’s AcclaimIP analytics software, last year there were 392,616 granted patents–a 15% increase from 2018. Further, there were 394,879 US applications published in 2019–a 5% increase from 2018.
What differentiates us from other IP management providers? We sat down with Anaqua CEO Bob Romeo, who talked about recent market events and shared with us Anaqua’s formula for designing and delivering the leading IP management software platform that helps organizations transform their IP into business success.
In the third post of our blog series, we spoke with Vincent Brault, Senior Vice President of Product and Innovation, about the importance of analytics and how new technology is helping to reshape its use in the IP industry. From internal portfolio performance insight to prosecution and competitive analysis, we learn more about how a 360 view is critical to an organization’s business decisions.
To continue our AQX blog series, we sat down with Dilip Phadke, Independent IP Consultant and a former Anaqua client, to learn more about AQX’s Financial Management solution. Dilip has many years’ experience working closely with Anaqua and our Customer Advisory Board on several projects including the development of our Financial Management solution.
Continuing our innovation, in early 2019 Anaqua released AQX, a next-generation software platform that enables organizations to align their IP portfolio strategy with their business objectives. The latest release, AQX 10.1, includes enhanced portfolio management features and integrated patent analytics dashboards that give users actionable information necessary for making better, more informed business decisions.
At Anaqua, we know a company is only as good as the people you hire. Their knowledge, passion, skills, and integrity are shaped by their families and the communities where they grew up. To say “thank you” to the societies that have helped our people and our company grow, we established – and this year expanded – our community service initiative: Anaqua Cares.
Every year, Discovery’s Shark Week gives tens of millions of viewers the thrill of being in the water with some of nature’s most fearsome predators. For some, this turns into a direct desire to be face-to-face with rows and rows of teeth, relying on cutting-edge intellectual property to keep them safe.
It has been another milestone year for our company – and one with continued momentum – all of which was celebrated at this year’s Anaqua User Conference (AUC) with our client community. The four-day event (March 25-28) was hosted at the Loews Royal Pacific at Universal Studios in sunny Orlando, Florida. This year marked AUC’s largest turnout to-date with the attendance of more than 200 IP thought leaders from around the world.
With sports fans around the world celebrating one of the greatest comebacks in sporting history after golfer Tiger Woods won the US Masters at Augusta, it is timely that World Intellectual Property Day on 26 April should be celebrating sporting heroes and the role of IP in sports.
As the latest events in the UK continue to unfold, and with the final Brexit deadline postponed again, it is difficult to predict if and when the UK will leave the EU. With Theresa May and the EU’s inability to decide on an orderly departure agreement, the threat of a no-deal Brexit is looming ever larger unless a further extension can be agreed. Regardless of how this shakes out, this article shares the latest updates on how a Brexit or no-deal Brexit turnout could potentially impact IP.
The accelerating pace of technological advancement is both unmistakable and inexorable today. All companies, high-tech or not, need to constantly innovate and push themselves in order to maintain a competitive advantage in an age where product features and capabilities are no longer enough to differentiate a company and create lasting value. At Anaqua, our client success business model compels us to provide the highest quality IP software and consulting services available. To accomplish this mission, we carefully and intelligently integrate new technologies that leverage the core strengths of our infrastructure, stability, security, and world-class workflow configuration, and layer in new tools to improve UI/UX, performance, and drive modernization.
SVP of Product Innovation and Marketing, Vincent Brault, weighs in on the industry's latest events and shares four critical considerations every IP and business professional should ask when evaluating their IP management solution.
The Pharmaceutical industry has always been a leader in partnering with academia, start-ups, biotechs and other large pharmaceutical companies to research, develop, distribute and resell lifesaving medicines worldwide. They have been doing this with great success and double-digit growth for over 50 years, and other industries are (finally) starting to take notice. The pharma industry has always taken the approach that “not invented here” should not be an obstacle in finding new novel approaches to human and animal healthcare.